Combining TNF inhibitors to anti-PD-1 and anti-CTLA-4 for the treatment of advanced melanoma patients
Year: 2021
Type: conference-paper
Study design: Clinical Trial
Source: HAL
Language: French
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7027369556
